According to the new market research report Spatial Genomics Market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170900551
The market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications in biomarker identification and drug discovery & development, and increasing investment in biopharmaceutical R&D.
Spatial Transcriptomics techniques accounted for the largest share of the spatial genomics market
Based on the technique, the spatial genomics and transcriptomics market is segmented into spatial transcriptomics techniques and spatial genomics analysis techniques. In 2019, the spatial transcriptomics techniques segment accounted for the largest share of the global spatial genomics market. Growth in this market segment can be attributed to the increasing demand for and high adoption rate of in situ sequencing techniques.
Academic & Research Institutes is the fastest-growing end-user segment of the market
Based on end-users, the spatial genomics market is segmented into academic & research institutes, contract research organizations (CROs), and pharmaceutical & biotechnology companies. In 2019, the academic & research institutes segment accounted for the largest share of the transcriptomics market. Market growth can largely be attributed to the increase in research intensity in this end-user segment and the availability of sufficient grants and funds for research.
North America accounted for the largest share of the spatial genomics market
North America held the largest share in the global market, followed by Europe, with a share of 21.6%. The large share of the North American regional segment can be attributed to the presence of well-established as well as emerging market players operating in the spatial genomics market in this region.
10X Genomics (US), NanoString Technologies Inc. (US), Illumina Inc. (US), and Bio-Rad Laboratories (US) are the prominent players operating in the transcriptomics market. Product launches, collaborations, agreements, expansions, and acquisitions are the key growth strategies adopted by a majority of the leading players in the market to gain a competitive edge in the market.
Request Free Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=170900551
Spatial Genomics and Transcriptomics Market worth $404 million by 2025
The global spatial genomics and transcriptomics market size was valued at USD 163.8 million in 2020 and is expected to expand at a CAGR of 11.1% from 2021 to 2028.
Architecture analysis of genome content in histological specimens is considered a cornerstone in several biomedical research and diagnostics.
The growth of this segment can also be attributed to the availability of automated sequencing methodologies, such as laser capture microdissection technique (LCM), to meet the expanding demand for nucleic acid sequencing of biological specimens or single cells.
For Right Perspective & Competitive Insights, Request a Sample @: https://www.grandviewresearch.com/industry-analysis/spatial-genomics-transcriptomics-market/request/rs1 The determination of spatial arrangement of molecules in cells and tissue samples is the basis for biological research and clinical practice and has gained the attention of several entities involved in the field of genetics.
Key Player Mentioned:Natera Inc.10x GenomicsDovetail GenomicsIllumina, Inc.S2 Genomics, Inc.NanoString Technologies, Inc.Seven Bridges GenomicsHorizon Discovery Group plcThe software segment is anticipated to grow lucratively throughout the forecast period.
The increasing volume of ongoing genomic research studies has led to the need for robust software solutions for data management and their interpretation.
The report consists of all the detailed profiles for the Transcriptomics Market major manufacturers and importers who are influencing the market.
This market study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period derived with the help of SWOT analysis.Global transcriptomics market is registering a healthy CAGR of 14.32% in the forecast period of 2019-2026.
This rise in market value can be attributed due to increase research and development in order to provide better treatment among patients worldwide.Get Inside Scoop of the report, request for sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-transcriptomics-market Market Definition: Global Transcriptomics MarketTranscriptome is set of all RNA particles in populace of the cell or one cell in the body.
These RNA cells can be dissected by different transcriptomics innovations that are utilized in considering a life form’s transcriptome.
From that point forward different organizations are engaged with creating innovations and items for transcriptomics.Segmentation: Global Transcriptomics MarketBy Product & ServicesInstrumentsConsumablesSoftwareServicesBy TechnologyMicroarrayReal Time-PCR (qPCR)SequencingBy TechnologyDiagnostics & Disease ProfilingDrug DiscoveryOthersBy End-UserPharmaceutical & Biotechnology CompaniesGovernment Institutes & Academic CentersContract research Organizations (CROs)By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)Key Vendors operating in the Market:Few of the major competitors currently working in the global transcriptomics market are Agilent Technologies, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc, Thermo Fisher Scientific, BD, Biological Industries, bioMérieux SA, Bio-Rad Laboratories, Inc, Cepheid, Takara Bio Inc., Cytognomix, Edico Genome (subsidiary of Illumina, Inc.), GENERAL ELECTRIC COMPANY, Siemens AG, QIAGEN, Merck KGaA, Kapa Biosystems, Spatial Transcriptomics among others.Focal points covered in this Statistical Survey reportThis Transcriptomics Market report provides pin point analysis of the market outlook and later establishes its comparison with current patterns.
Also it creates a relationship of the market outlook with Porter Five Force AnalysisThis research report is inclusive concept of the market progression.
The global spatial genomics and transcriptomics market size was valued at USD 163.8 million in 2020 and is expected to expand at a CAGR of 11.1% from 2021 to 2028.
Architecture analysis of genome content in histological specimens is considered a cornerstone in several biomedical research and diagnostics.
The growth of this segment can also be attributed to the availability of automated sequencing methodologies, such as laser capture microdissection technique (LCM), to meet the expanding demand for nucleic acid sequencing of biological specimens or single cells.
For Right Perspective & Competitive Insights, Request a Sample @: https://www.grandviewresearch.com/industry-analysis/spatial-genomics-transcriptomics-market/request/rs1 The determination of spatial arrangement of molecules in cells and tissue samples is the basis for biological research and clinical practice and has gained the attention of several entities involved in the field of genetics.
Key Player Mentioned:Natera Inc.10x GenomicsDovetail GenomicsIllumina, Inc.S2 Genomics, Inc.NanoString Technologies, Inc.Seven Bridges GenomicsHorizon Discovery Group plcThe software segment is anticipated to grow lucratively throughout the forecast period.
The increasing volume of ongoing genomic research studies has led to the need for robust software solutions for data management and their interpretation.
The report consists of all the detailed profiles for the Transcriptomics Market major manufacturers and importers who are influencing the market.
This market study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period derived with the help of SWOT analysis.Global transcriptomics market is registering a healthy CAGR of 14.32% in the forecast period of 2019-2026.
This rise in market value can be attributed due to increase research and development in order to provide better treatment among patients worldwide.Get Inside Scoop of the report, request for sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-transcriptomics-market Market Definition: Global Transcriptomics MarketTranscriptome is set of all RNA particles in populace of the cell or one cell in the body.
These RNA cells can be dissected by different transcriptomics innovations that are utilized in considering a life form’s transcriptome.
From that point forward different organizations are engaged with creating innovations and items for transcriptomics.Segmentation: Global Transcriptomics MarketBy Product & ServicesInstrumentsConsumablesSoftwareServicesBy TechnologyMicroarrayReal Time-PCR (qPCR)SequencingBy TechnologyDiagnostics & Disease ProfilingDrug DiscoveryOthersBy End-UserPharmaceutical & Biotechnology CompaniesGovernment Institutes & Academic CentersContract research Organizations (CROs)By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)Key Vendors operating in the Market:Few of the major competitors currently working in the global transcriptomics market are Agilent Technologies, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc, Thermo Fisher Scientific, BD, Biological Industries, bioMérieux SA, Bio-Rad Laboratories, Inc, Cepheid, Takara Bio Inc., Cytognomix, Edico Genome (subsidiary of Illumina, Inc.), GENERAL ELECTRIC COMPANY, Siemens AG, QIAGEN, Merck KGaA, Kapa Biosystems, Spatial Transcriptomics among others.Focal points covered in this Statistical Survey reportThis Transcriptomics Market report provides pin point analysis of the market outlook and later establishes its comparison with current patterns.
Also it creates a relationship of the market outlook with Porter Five Force AnalysisThis research report is inclusive concept of the market progression.